Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic

Author:

Karami Sara1,Asonye Cooma1,Pinnow Ellen1ORCID,Pratt Valerie1,McCulley Lynda1ORCID,Dwumfour Nana1,Zhou Esther H.1ORCID

Affiliation:

1. Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA

Funder

U.S. FDA

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Reference71 articles.

1. Burden and characteristics of COVID-19 in the United States during 2020

2. Scientific consensus on the COVID-19 pandemic: we need to act now

3. Centers for Disease Control and Prevention. Symptoms of COVID-19. 2022. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html#:∼:text=Fever%20or%20chills,Fatigue

4. World Health Organization. Home care for patients with suspected or confirmed COVID-19 and management of their contacts: interim guidance. World Health Organization. 2020. https://apps.who.int/iris/handle/10665/333782

5. Pain Management During the COVID-19 Pandemic

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3